Cyanuric acid-13C3,98.0%
产品编号：Bellancom-W010407S| CAS NO：201996-37-4| 分子式：13C3H3N3O3| 分子量：132.05
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，
Cyanuric acid-13C3
| 产品介绍 | Cyanuric acid-13C3 是 13C 标记的 Cyanuric acid。 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | Cyanuric acid-13C3 is the 13C labeled Cyanuric acid. | ||||||||||||||||
| 体外研究 |
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
| 体内研究 | |||||||||||||||||
| 体内研究 | |||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| 溶解性数据 |
In Vitro:
DMSO : 125 mg/mL (946.61 mM; Need ultrasonic) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 |
| ||||||||||||||||
| 参考文献 | |||||||||||||||||
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H319 |
| 警示性声明 | P305 + P351 + P338 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危害码 (欧洲) | Xi |
| 风险声明 (欧洲) | 36 |
| 安全声明 (欧洲) | 26 |
| 危险品运输编码 | NONH for all modes of transport |
|
~86%
201996-37-4 |
| 文献：Luo, Yong; Zhang, Liya; Yang, Weicheng; Liu, Weixia; Lu, Weijing; Li, Meihua Journal of Labelled Compounds and Radiopharmaceuticals, 2011 , vol. 54, # 4 p. 171 - 172 |
| 上游产品 1 | |
|---|---|
| 下游产品 0 | |
有竞争力的价格匹配竞争对手的价格
极速物流效率为先
技术支持专业经验 贴心服务
现货库存50000+库存
浙公网安备 33010802013016号
